查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379133

2023-2028 年按產品類型（智慧血糖儀、智慧胰島素幫浦、智慧胰島素筆、應用程式）、裝置類型（手持裝置、穿戴式裝置）和區域分類的數位糖尿病管理市場報告

Digital Diabetes Management Market Report by Product Type (Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens, Apps), Device Type (Handheld Devices, Wearable Devices), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球數位糖尿病管理市場規模達108億美元。展望未來， IMARC Group預計到2028年市場規模將達到360億美元，2022-2028年複合年成長率（CAGR）為22.2%。糖尿病盛行率的上升、重大的技術進步、向以患者為中心的護理的轉變、有利的政府舉措、人工智慧整合、遠距醫療和遠端患者監測解決方案的日益採用以及戰略合作是推動市場的一些主要因素。

數位化糖尿病管理是指利用科技和數位解決方案幫助個人監測和控制其糖尿病狀況。這些數位工具和應用程式提供各種功能，有助於追蹤血糖水平、藥物依從性、身體活動和飲食攝取量。透過利用智慧型手機、穿戴式裝置和雲端的平台，數位糖尿病管理可以實現即時資料收集和分析，促進患者更好的自我管理和參與。數位糖尿病管理的主要優勢之一是它能夠根據收集的資料提供個人化的見解和可行的建議。這使患者能夠對其生活方式選擇和治療計劃做出明智的決定。此外，醫療保健提供者可以全面了解患者的健康狀況，以便在必要時進行遠端監控和及時干預。此外，這些技術透過互動功能和教育資源促進持續參與和積極性，有助於改善患者的治療效果。它們還促進患者和醫療保健專業人員之間的無縫溝通，從而增強整體護理體驗。

全球糖尿病盛行率不斷上升，對有效、便利的糖尿病管理解決方案產生了巨大需求。數位糖尿病管理工具提供即時監控和個人化護理，使其成為患者和醫療保健提供者等有吸引力的選擇。此外，在糖尿病照護中，人們越來越重視患者賦權和自我管理。數位糖尿病管理解決方案透過提供輕鬆的資訊取得、個人化見解以及監測和依從性工具，使患者能夠掌控自己的健康。除此之外，將人工智慧和機器學習演算法整合到數位糖尿病管理平台中可以實現預測分析和個人化建議。這些技術增強了治療計劃和干涉措施，推動了市場需求。除此之外，遠距醫療和遠距患者監測解決方案的日益普及進一步推動了對數位糖尿病管理工具的需求。這些技術使醫療保健提供者能夠遠端監控患者的健康狀況並在必要時進行干預，從而改善患者護理和便利性。與此一致的是，市場見證了數位健康公司和製藥公司之間的合作，從而實現了糖尿病管理解決方案與藥物和治療方案的整合。這種合作夥伴關係擴大了市場範圍並增強了產品供應。此外，在糖尿病照護中，人們越來越重視患者賦權和自我管理。數位糖尿病管理解決方案透過提供輕鬆的資訊取得、個人化見解以及監測和依從性工具，使患者能夠掌控自己的健康。此外，各國政府正在積極推動數位健康解決方案，包括數位糖尿病管理，以改善醫療結果並降低醫療成本。激勵和支持政策進一步推動了市場的成長。

數位糖尿病管理市場趨勢/促進因素：

技術進步

智慧型手機、穿戴式裝置和網路連線的出現徹底改變了患者和醫療保健提供者管理糖尿病的方式。這些進步使得方便用戶使用的行動應用程式和穿戴式裝置的開發成為可能，從而促進無縫資料收集，例如血糖水平和身體活動。此外，基於雲端的平台已經出現，可以即時安全地儲存和分析患者的健康資料。資料分析和人工智慧的整合透過提供個人化見解和預測分析，進一步增強了這些解決方案的功能，使患者能夠就糖尿病管理做出明智的決策。總體而言，技術進步顯著提高了數位糖尿病管理工具的有效性和可近性，使其成為現代醫療保健不可或缺的一部分。

自我管理意識不斷增強

數位化糖尿病管理解決方案在推動這一趨勢方面發揮了至關重要的作用。這些工具讓患者能夠獨立監測自己的健康和生活習慣，讓他們有掌控自己病情的感覺。透過直覺的介面和教育資源，數位平台向患者傳授糖尿病管理知識，包括飲食選擇、運動習慣和藥物依從性。透過積極讓患者參與護理，這些解決方案可以提高治療依從性和整體健康結果。此外，透過數位平台存取健康資料以及與醫療保健提供者溝通的便利性促進了患者的更多參與，從而形成了更具協作性的糖尿病管理方法。

有利的政府舉措

世界各國政府已經認知到數位醫療解決方案在改善醫療保健服務和結果方面的潛在好處。因此，他們實施了各種措施和政策來支持採用數位糖尿病管理和其他數位健康技術。已向醫療保健組織和技術公司提供激勵、補貼和贈款，以鼓勵開發和部署創新的數位糖尿病管理解決方案。此外，還建立了監管框架來確保這些技術的安全性和有效性。這些支持措施為市場成長、吸引投資和促進創新創造了有利的環境。因此，全球數位糖尿病管理市場經歷了顯著擴張，公共和私營部門之間的合作不斷增加，以推動該領域的進步。

數位糖尿病管理產業細分：

IMARC Group提供了全球數位糖尿病管理市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品類型和設備類型對市場進行了分類。

按產品類型分類：

智慧型血糖儀

智慧胰島素泵

智慧胰島素筆

應用

智慧血糖儀佔據市場主導地位

該報告根據產品類型對市場進行了詳細的細分和分析。這包括智慧血糖儀、智慧胰島素幫浦、智慧胰島素筆和應用程式。報告稱，智慧血糖儀佔據了最大的細分市場。

智慧血糖儀提供先進的功能和連接選項，滿足對技術先進的糖尿病管理解決方案不斷成長的需求。這些設備可以與智慧型手機和其他數位平台無縫同步，使用戶可以輕鬆存取即時血糖資料。此外，全球糖尿病盛行率不斷上升，導致對準確且使用者友善的血糖監測設備的需求增加。智慧型血糖儀可提供精確的讀數，降低糖尿病管理出錯的風險，並提高患者對治療計劃的依從性。除此之外，糖尿病照護中對自我管理和患者賦權的重視進一步推動了智慧血糖儀的普及。這些設備使個人能夠獨立追蹤自己的血糖水平，促進積極主動的糖尿病管理方法並培養對病情的控制感。此外，醫療保健提供者擴大採用遠距醫療和遠端監控解決方案，而智慧血糖儀正好符合這一趨勢。將資料遠端傳輸給醫療保健專業人員的能力有助於及時干預和個人化護理，使這些設備成為現代糖尿病管理中不可或缺的工具。

依設備類型細分：

手持裝置

穿戴式裝置

穿戴式裝置佔據最大市場佔有率

報告還根據設備類型提供了詳細的市場細分和分析。這包括手持設備和穿戴式裝置。報告顯示，穿戴式裝置佔據了最大的市場佔有率。

穿戴式裝置提供了一種無縫且非侵入性的方式來監測各種健康參數，這對於尋求持續健康追蹤而又不中斷日常生活的個人來說非常有吸引力。在糖尿病管理的背景下，配備感測器的穿戴式裝置可以監測血糖水平、體力活動、心率和其他相關資料。此外，包括糖尿病在內的慢性病的盛行率不斷上升，推動了對個人化和主動醫療保健解決方案的需求。穿戴式裝置可實現即時資料收集和分析，為使用者提供有關其健康狀況和管理病情進展的寶貴見解。除此之外，穿戴式裝置見證了顯著的技術進步，提高了其準確性、功能和整體使用者體驗。這些創新擴大了穿戴式裝置的範圍，使其成為滿足各種醫療保健需求（包括糖尿病管理）的多功能工具。此外，穿戴式裝置與智慧型手機和其他數位平台的整合促進了無縫資料共享、與醫療保健提供者的通訊以及與其他數位健康應用程式的整合。這種連接性進一步提高了穿戴式裝置在醫療保健生態系統中的價值。此外，人們對預防性醫療保健和健康的日益關注推動了注重健康的個人對穿戴式裝置的採用，使其成為主流趨勢。便利性、個人化見解、技術進步以及向主動健康管理的轉變相結合，推動穿戴式設備成為數位健康設備市場的最大部分，包括那些專為糖尿病管理而設計的設備。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美在市場上表現出明顯的主導地位

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是數位糖尿病管理的最大市場。

北美的糖尿病盛行率很高，1 型和 2 型糖尿病影響了很大一部分人口。龐大的患者群體對創新、有效的糖尿病管理解決方案（包括數位技術）產生了強烈需求。此外，該地區擁有發達的醫療基礎設施和先進的技術能力。該地區處於數位醫療採用的前沿，智慧型手機、穿戴式裝置和遠距醫療平台的廣泛使用。這種技術準備促進了醫療保健系統和患者群體中數位糖尿病管理工具的整合和採用。此外，促進數位醫療採用的有利政府政策和措施進一步加速了市場的成長。這些政策包括鼓勵醫療保健提供者採用數位解決方案、對遠距醫療服務的報銷支持以及鼓勵數位醫療技術創新的監管框架。此外，北美數位健康產業的主要參與者和精通科技的新創公司的存在也促成了一個充滿活力和競爭的市場。這些公司投資於研發，產生了廣泛的尖端數位糖尿病管理解決方案，可滿足各種患者的需求。

競爭格局：

市場主要參與者在研發方面投入巨資，以提高數位糖尿病管理解決方案的能力。他們不斷升級智慧血糖儀、穿戴式裝置、行動應用程式和雲端平台，為用戶提供增強的功能、更高的準確性和更好的用戶體驗。將人工智慧、機器學習和資料分析整合到這些解決方案中，實現了個人化見解、預測分析和更有效的治療建議。此外，主要參與者還與各個利害關係人建立了合作和夥伴關係，以擴大其市場範圍並增強產品供應。這些合作夥伴關係通常涉及製藥公司、醫療保健提供者和遠距醫療平台。透過將數位糖尿病管理解決方案與藥物治療、電子健康記錄和遠距醫療服務相結合，這些公司可以為糖尿病患者提供全面、無縫的醫療保健體驗。除此之外，了解患者參與和賦權在糖尿病護理中的重要性，主要參與者專注於開發方便用戶使用且以患者為中心的解決方案。他們優先考慮使用者體驗，提供直覺的介面、教育資源和個人化指導，以鼓勵自我管理和生活方式的改變。目標是促進長期參與和遵守治療計劃，從而改善患者的健康結果。除此之外，認知到健康資料的敏感性，主要參與者都非常重視資料安全和隱私。它們符合 HIPAA（健康保險流通與責任法案）和 GDPR（一般資料保護規範）等監管標準，確保病患資訊的安全儲存和傳輸。這種對資料安全的承諾在使用者和醫療保健專業人員之間建立了信任，進一步推動了數位糖尿病管理解決方案的採用。

市場研究報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

雅培實驗室

艾康實驗室公司

Ascensia 糖尿病照護控股公司（PHC 控股公司）

貝克頓迪金森公司

德克斯康沃爾

F.霍夫曼-拉羅氏股份公司

美敦力公司

諾和諾德公司

Tandem 糖尿病護理公司

泰爾茂株式會社

最近的發展：

生物技術和製藥行業的兩家知名企業諾和諾德公司(Novo Nordisk A/S) 和Aspect Biosystems 最近宣佈建立戰略合作夥伴關係，其共同目標是推進生物列印組織療法的開發，以應對糖尿病和肥胖症的挑戰。此次合作代表了再生醫學領域向前邁出的重要一步，並為患有這些慢性代謝性疾病的患者帶來了廣闊的前景。

Tandem Diabetes Care Inc. 最近發表了一項涉及其 Control-IQ 技術的重要薈萃分析結果。這項綜合研究表明，自動校正推注對第 1 型糖尿病患者的血糖控制具有積極的臨床影響，代表了糖尿病護理的重大進步。

Terumo Corporation 和專門從事糖尿病管理的著名數位健康平台 Glooko 共同宣布開展合作，旨在開發一種用於糖尿病資料共享的新型創新解決方案。此次合作匯集了 Terumo 在醫療設備方面的專業知識和 Glooko 在數位健康技術方面的熟練程度，最終目標是透過改善資料可近性和連接性來加強糖尿病護理。

本報告回答的關鍵問題：

  • 迄今為止，全球數位糖尿病管理市場表現如何，未來幾年將如何表現？
  • 全球數位糖尿病管理市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球數位糖尿病管理市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的數位糖尿病管理市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 數位糖尿病管理市場中最具吸引力的產品類型是什麼？
  • 根據設備類型分類的市場是怎麼樣的？
  • 數位糖尿病管理市場中哪種設備類型最具吸引力？
  • 全球數位化糖尿病管理市場的競爭格局如何？
  • 全球數位糖尿病管理市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球數位糖尿病管理市場表現如何，未來幾年將如何表現？
  • 全球數位糖尿病管理市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球數位糖尿病管理市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的數位糖尿病管理市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 數位糖尿病管理市場中最具吸引力的產品類型是什麼？
  • 根據設備類型分類的市場是怎麼樣的？
  • 數位糖尿病管理市場中哪種設備類型最具吸引力？
  • 全球數位化糖尿病管理市場的競爭格局如何？
  • 全球數位糖尿病管理市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球數位糖尿病管理市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 智慧型血糖儀
    • 市場走向
    • 市場預測
  • 智慧胰島素泵
    • 市場走向
    • 市場預測
  • 智慧胰島素筆
    • 市場走向
    • 市場預測
  • 應用
    • 市場走向
    • 市場預測

第 7 章：按設備類型分類的市場細分

  • 手持裝置
    • 市場走向
    • 市場預測
  • 穿戴式裝置
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • ACON Laboratories Inc
    • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
    • Becton, Dickinson and Company
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Medtronic plc
    • Novo Nordisk A/S
    • Tandem Diabetes Care Inc.
    • Terumo Corporation
Product Code: SR112023A4081

Abstract

The global digital diabetes management market size reached US$ 10.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.0 Billion by 2028, exhibiting a growth rate (CAGR) of 22.2% during 2022-2028. The rising prevalence of diabetes, significant technological advancements, a shift toward patient-centric care, favorable government initiatives, AI integration, increasing adoption of telehealth and remote patient monitoring solutions, and strategic collaborations are some of the major factors propelling the market.

Digital diabetes management refers to the utilization of technology and digital solutions to assist individuals in monitoring and controlling their diabetes condition. These digital tools and applications offer various functionalities that aid in tracking blood glucose levels, medication adherence, physical activity, and dietary intake. By leveraging smartphones, wearable devices, and cloud-based platforms, digital diabetes management enables real-time data collection and analysis, fostering better self-management and engagement for patients. One of the key advantages of digital diabetes management is its ability to provide personalized insights and actionable recommendations based on the data collected. This empowers patients to make informed decisions about their lifestyle choices and treatment plans. Additionally, healthcare providers can access a comprehensive view of the patient's health, allowing for remote monitoring and timely interventions when necessary. Furthermore, these technologies contribute to better patient outcomes by promoting continuous engagement and motivation through interactive features and educational resources. They also facilitate seamless communication between patients and healthcare professionals, enhancing the overall care experience.

The rising prevalence of diabetes worldwide has created a significant demand for effective and convenient solutions to manage the condition. Digital diabetes management tools offer real-time monitoring and personalized care, making them attractive options for patients and healthcare providers alike. Additionally, there is a growing emphasis on patient empowerment and self-management in diabetes care. Digital diabetes management solutions empower patients to take control of their health by providing easy access to information, personalized insights, and tools for monitoring and adherence. Other than this, the integration of artificial intelligence and machine learning algorithms into digital diabetes management platforms has enabled predictive analysis and personalized recommendations. These technologies enhance treatment plans and interventions, driving market demand. Besides this, the increasing adoption of telehealth and remote patient monitoring solutions has further fueled the demand for digital diabetes management tools. These technologies enable healthcare providers to remotely monitor patients' health and intervene when necessary, improving patient care and convenience. In line with this, the market has witnessed collaborations between digital health companies and pharmaceutical firms, leading to the integration of diabetes management solutions with medication and treatment regimens. Such partnerships expand the market reach and enhance product offerings. Furthermore, there is a growing emphasis on patient empowerment and self-management in diabetes care. Digital diabetes management solutions empower patients to take control of their health by providing easy access to information, personalized insights, and tools for monitoring and adherence. Moreover, governments in various countries are actively promoting the adoption of digital health solutions, including digital diabetes management, to improve healthcare outcomes and reduce healthcare costs. Incentives and supportive policies have further boosted the market's growth.

Digital Diabetes Management Market Trends/Drivers:

Technological Advancements

The advent of smartphones, wearable devices, and internet connectivity has revolutionized the way patients and healthcare providers manage diabetes. These advancements have enabled the development of user-friendly mobile applications and wearable gadgets that facilitate seamless data collection, such as blood glucose levels and physical activity. Additionally, cloud-based platforms have emerged, allowing secure storage and analysis of patients' health data in real-time. The integration of data analytics and artificial intelligence has further enhanced the capabilities of these solutions by providing personalized insights and predictive analysis, empowering patients to make informed decisions about their diabetes management. Overall, technological advancements have significantly improved the effectiveness and accessibility of digital diabetes management tools, making them an integral part of modern healthcare.

Growing Awareness About Self-Management

Digital diabetes management solutions have played a crucial role in promoting this trend. These tools offer patients the ability to monitor their health and lifestyle habits independently, providing them with a sense of control over their condition. Through intuitive interfaces and educational resources, digital platforms educate patients about diabetes management, including dietary choices, exercise routines, and medication adherence. By actively involving patients in their care, these solutions improve treatment compliance and overall health outcomes. Additionally, the convenience of accessing health data and communicating with healthcare providers through digital platforms fosters greater patient engagement, leading to a more collaborative approach to diabetes management.

Favorable Government Initiatives

Governments worldwide have recognized the potential benefits of digital health solutions in improving healthcare delivery and outcomes. Consequently, they have implemented various initiatives and policies to support the adoption of digital diabetes management and other digital health technologies. Incentives, subsidies, and grants have been provided to healthcare organizations and technology companies to encourage the development and deployment of innovative digital diabetes management solutions. Moreover, regulatory frameworks have been established to ensure the safety and efficacy of these technologies. These supportive measures have created a conducive environment for market growth, attracting investment and fostering innovation. As a result, the global digital diabetes management market has experienced significant expansion, with increasing collaborations between public and private sectors to drive advancements in this domain.

Digital Diabetes Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global digital diabetes management market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type and device type.

Breakup by Product Type:

Smart Glucose Meter

Smart Insulin Pumps

Smart Insulin Pens

Apps

Smart glucose meter dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes smart glucose meter, smart insulin pumps, smart insulin pens, and apps. According to the report, smart glucose meter represented the largest segment.

Smart glucose meters offer advanced features and connectivity options that cater to the growing demand for technologically sophisticated diabetes management solutions. These devices can seamlessly sync with smartphones and other digital platforms, allowing users to access their real-time blood glucose data conveniently. Additionally, the rising prevalence of diabetes worldwide has led to an increased demand for accurate and user-friendly glucose monitoring devices. Smart glucose meters provide precise readings, reducing the risk of errors in diabetes management and enhancing patient compliance with treatment plans. Other than this, the emphasis on self-management and patient empowerment in diabetes care has further boosted the popularity of smart glucose meters. These devices enable individuals to track their glucose levels independently, promoting a proactive approach to diabetes management and fostering a sense of control over the condition. Moreover, healthcare providers are increasingly adopting telehealth and remote monitoring solutions, and smart glucose meters align well with this trend. The ability to remotely transmit data to healthcare professionals facilitates timely interventions and personalized care, making these devices indispensable tools in modern diabetes management.

Breakup by Device Type:

Handheld Devices

Wearable Devices

Wearable devices hold the largest share in the market

A detailed breakup and analysis of the market based on the device type has also been provided in the report. This includes handheld devices and wearable devices. According to the report, wearable devices accounted for the largest market share.

Wearable devices offer a seamless and non-intrusive way to monitor various health parameters, making them highly attractive to individuals seeking continuous health tracking without disruption to their daily routines. In the context of diabetes management, wearable devices equipped with sensors can monitor blood glucose levels, physical activity, heart rate, and other relevant data. Additionally, the increasing prevalence of chronic diseases, including diabetes, has driven the demand for personalized and proactive healthcare solutions. Wearable devices enable real-time data collection and analysis, providing users with valuable insights into their health status and progress in managing their condition. Other than this, wearable devices have witnessed remarkable technological advancements, enhancing their accuracy, functionality, and overall user experience. These innovations have broadened the scope of wearable devices, making them versatile tools that cater to diverse healthcare needs, including diabetes management. Furthermore, the integration of wearable devices with smartphones and other digital platforms has facilitated seamless data sharing, communication with healthcare providers, and integration with other digital health applications. This connectivity has further enhanced the value of wearable devices in the healthcare ecosystem. Moreover, the growing focus on preventive healthcare and wellness has fueled the adoption of wearable devices by health-conscious individuals, making them a mainstream trend. The combination of convenience, personalized insights, technological advancements, and the shift towards proactive health management has propelled wearable devices to become the largest segment in the market for digital health devices, including those designed for diabetes management.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for digital diabetes management.

North America has a high prevalence of diabetes, with both type 1 and type 2 diabetes affecting a significant portion of the population. This substantial patient pool has created a strong demand for innovative and effective diabetes management solutions, including digital technologies. Additionally, the region has a well-developed healthcare infrastructure and advanced technological capabilities. The region is at the forefront of digital health adoption, with extensive usage of smartphones, wearables, and telehealth platforms. This technological readiness has facilitated the integration and adoption of digital diabetes management tools across healthcare systems and patient populations. Furthermore, favorable government policies and initiatives promoting digital health adoption have further accelerated the growth of the market. These policies include incentives for healthcare providers to adopt digital solutions, reimbursement support for telehealth services, and regulatory frameworks that encourage innovation in digital health technologies. Moreover, the presence of major players and tech-savvy startups in the digital health industry within North America has contributed to a vibrant and competitive market. These companies have invested in research and development, resulting in a wide range of cutting-edge digital diabetes management solutions that cater to various patient needs.

Competitive Landscape:

Major players in the market have invested heavily in research and development to advance the capabilities of digital diabetes management solutions. They continuously upgrade their smart glucose meters, wearable devices, mobile applications, and cloud-based platforms to provide users with enhanced functionalities, improved accuracy, and better user experiences. Integration of artificial intelligence, machine learning, and data analytics into these solutions has enabled personalized insights, predictive analysis, and more effective treatment recommendations. Additionally, key players have formed collaborations and partnerships with various stakeholders to expand their market reach and enhance product offerings. These partnerships often involve pharmaceutical companies, healthcare providers, and telehealth platforms. By integrating their digital diabetes management solutions with medication regimens, electronic health records, and telemedicine services, these companies can offer comprehensive and seamless healthcare experiences for individuals with diabetes. Other than this, understanding the importance of patient engagement and empowerment in diabetes care, key players have focused on developing user-friendly and patient-centric solutions. They prioritize user experience, offering intuitive interfaces, educational resources, and personalized coaching to encourage self-management and lifestyle changes. The goal is to foster long-term engagement and adherence to treatment plans, leading to improved health outcomes for patients. Besides this, recognizing the sensitivity of health data, major players have placed a strong emphasis on data security and privacy. They comply with regulatory standards such as HIPAA (Health Insurance Portability and Accountability Act) and GDPR (General Data Protection Regulation) to ensure the safe storage and transmission of patient information. This commitment to data security builds trust among users and healthcare professionals, further driving the adoption of their digital diabetes management solutions.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

ACON Laboratories Inc

Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)

Becton, Dickinson and Company

Dexcom Inc.

F. Hoffmann-La Roche AG

Medtronic plc

Novo Nordisk A/S

Tandem Diabetes Care Inc.

Terumo Corporation

Recent Developments:

Novo Nordisk A/S and Aspect Biosystems, two prominent players in the biotechnology and pharmaceutical industries, recently announced a strategic partnership with the shared objective of advancing the development of bioprinted tissue therapeutics tailored to address the challenges of diabetes and obesity. This collaboration represents a significant step forward in the field of regenerative medicine and holds promising potential for patients suffering from these chronic metabolic disorders.

Tandem Diabetes Care Inc. recently announced the results of a significant meta-analysis involving their Control-IQ technology. This comprehensive study demonstrates the positive clinical impact of automatic correction bolusing on glucose control in individuals with Type 1 diabetes, representing a substantial advancement in diabetes care.

Terumo Corporation and Glooko, a prominent digital health platform specializing in diabetes management, have jointly announced a collaboration aimed at developing a new and innovative solution for diabetes data sharing. This partnership brings together Terumo's expertise in medical devices and Glooko's proficiency in digital health technologies, with the ultimate goal of enhancing diabetes care through improved data accessibility and connectivity.

Key Questions Answered in This Report:

  • How has the global digital diabetes management market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global digital diabetes management market?
  • What is the impact of each driver, restraint, and opportunity on the global digital diabetes management market?
  • What are the key regional markets?
  • Which countries represent the most attractive digital diabetes management market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the digital diabetes management market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the digital diabetes management market?
  • What is the competitive structure of the global digital diabetes management market?
  • Who are the key players/companies in the global digital diabetes management market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Diabetes Management Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Smart Glucose Meter
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Smart Insulin Pumps
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Smart Insulin Pens
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Apps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Handheld Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Wearable Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 ACON Laboratories Inc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Becton, Dickinson and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Dexcom Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 F. Hoffmann-La Roche AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Medtronic plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novo Nordisk A/S
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Tandem Diabetes Care Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Terumo Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Digital Diabetes Management Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Diabetes Management Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Digital Diabetes Management Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Digital Diabetes Management Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Digital Diabetes Management Market: Breakup by Device Type (in %), 2022
  • Figure 6: Global: Digital Diabetes Management Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Digital Diabetes Management (Smart Glucose Meter) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Digital Diabetes Management (Smart Glucose Meter) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Digital Diabetes Management (Smart Insulin Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Digital Diabetes Management (Smart Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Digital Diabetes Management (Smart Insulin Pens) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Digital Diabetes Management (Smart Insulin Pens) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Digital Diabetes Management (Apps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Digital Diabetes Management (Apps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Digital Diabetes Management (Handheld Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Digital Diabetes Management (Handheld Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Digital Diabetes Management (Wearable Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Digital Diabetes Management (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Digital Diabetes Management Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Digital Diabetes Management Industry: SWOT Analysis
  • Figure 69: Global: Digital Diabetes Management Industry: Value Chain Analysis
  • Figure 70: Global: Digital Diabetes Management Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Diabetes Management Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Digital Diabetes Management Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Digital Diabetes Management Market Forecast: Breakup by Device Type (in Million US$), 2023-2028
  • Table 4: Global: Digital Diabetes Management Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Digital Diabetes Management Market: Competitive Structure
  • Table 6: Global: Digital Diabetes Management Market: Key Players